Dermatology
News
Studies Reinforce JAK Inhibitor Efficacy for Most Challenging Alopecia Types
FROM AAD 2024
SAN DIEGO —
News
Sublingual Immunotherapy Safe, Effective for Older Kids
“So now we have the best of both worlds. We harness the safety of SLIT for the first 1-2 years, with the effectiveness of OIT for the remainder of...
News
Inside the 2024 AAD Acne Guidelines: New Therapies Join Old Standbys
Recommendations include multimodal therapy and retinoids.
News
Latest NCCN Melanoma Guidelines Capture Dynamic of Constantly Evolving Best Practice
Many of the changes in the 2024 NCCN guidelines capture incremental advances rather than a radical departure from previous practice.
News
Sulfites Selected as ACDS Allergen of the Year
The exclusion of sulfites from most patch test series means that sulfite allergy diagnoses are often missed, despite the wide range of potential...
News
TIL for Melanoma: What Are the Costs and Other Challenges to Getting It to Patients?
Doctors are prepared to advocate for insurance coverage of the newly approved therapy on a case-by-case basis.
News
Study Finds No Increased Cancer Risk With Spironolactone
Spironolactone, used off-label for several skin conditions in women, carries a warning about an increased tumor risk associated with high doses in...
News
Another Neurotoxin for Frown Lines Enters the Market
FDA approved letibotulinumtoxinA-wlbg, which has been used in South Korea, to treat glabellar lines in adults.
News
How Good are Tools to Screen for Spondyloarthritis in Patients With Psoriasis, Uveitis, IBD?
A comparison of screening tools for SpA in conditions that commonly co-occur with the disease revealed few screening tool options for patients...
News
Older Age Confers a Higher Risk for Second Primary Melanoma: Study
Knowledge about one's risk for a second primary invasive melanoma over time remains incomplete.